Astrocyte Pharmaceuticals Inc.

From concussions to severe stroke, brain injury is vast, and Astrocyte’s Phase 2 therapy shows broad, reproducible benefits with real potential for impact.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Groton, CT, USA
  • Currency USD
  • Founded August 2014
  • Employees 5
  • Incorporation Type C-corp
  • Website astrocytepharma.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free